Review: could Cymbalta cause Metastases To Lymph Nodes?


Summary

Metastases to lymph nodes is found among people who take Cymbalta, especially for people who are female, 50-59 old also take medication Zometa, and have Bone density abnormal . We study 46,365 people who have side effects while taking Cymbalta from FDA and social media. Among them, 39 have Metastases to lymph nodes. Find out below who they are, when they have Metastases to lymph nodes and more.

You are not alone

Join a support group for people who take Cymbalta and have Metastases to lymph nodes >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Cymbalta

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. (latest outcomes from Cymbalta 48,467 users)

Metastases To Lymph Nodes

Metastases to lymph nodes (cancer spreads to lymph node) has been reported by people with breathing difficulty, bone callus excessive, respiratory acidosis, high blood cholesterol (latest reports from 2,740 Metastases to lymph nodes patients).

On Jul, 29, 2016

46,365 people reported to have side effects when taking Cymbalta.
Among them, 39 people (0.08%) have Metastases To Lymph Nodes


Number of reports submitted per year:

Could Cymbalta cause Metastases to lymph nodes?

Gender of people who have Metastases To Lymph Nodes when taking Cymbalta *:

  • female: 94.87 %
  • male: 5.13 %

Age of people who have Metastases To Lymph Nodes when taking Cymbalta *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.57 %
  • 50-59: 75.0 %
  • 60+: 21.43 %

Top conditions involved for these people *:

  • Metastases To Bone (12 people)
  • Bone Density Abnormal (12 people)
  • Breast Cancer Metastatic (9 people)
  • Anaemia (5 people)
  • Osteoporosis (3 people)

Top co-used drugs for these people *:

  • Zometa (35 people)
  • Prilosec (28 people)
  • Wellbutrin (21 people)
  • Taxol (21 people)
  • Lexapro (21 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Metastases to lymph nodes when taking Cymbalta?


Recent conversations of related support groups:

Browse all side effects of Cymbalta

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Metastases to lymph nodes

Metastases to lymph nodes

Could your condition cause Metastases to lymph nodes

Metastases to lymph nodes

Can you answer these questions?

More questions for: Cymbalta, Metastases to lymph nodes

You may be interested in these reviews

More reviews for: Cymbalta, Metastases to lymph nodes


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.